Eton Pharmaceuticals, Inc. Board of Directors

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1. It also provides Zeneo hydrocortisone autoinjector for the treatment of adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Mr. Sean E. Brynjelsen

Mr. Sean E. Brynjelsen

President, CEO & Director

Mr. David C. Krempa

Mr. David C. Krempa

Chief Business Officer

Danka Radosavljevic

Danka Radosavljevic

Senior Vice President of Quality & Operations

Mr. James R. Gruber CPA

Mr. James R. Gruber CPA

CFO, Treasurer & Secretary

Mr. Scott Grossenbach

Mr. Scott Grossenbach

Vice President of Sales Operations

Mr. Kevin Guthrie

Mr. Kevin Guthrie

Executive VP of Commercial Operations

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.